Published in Arch Gen Psychiatry on December 01, 2006
Oxytocin: the great facilitator of life. Prog Neurobiol (2009) 3.71
Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull (2006) 2.92
Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) (2008) 2.64
Neurophysiological biomarkers for drug development in schizophrenia. Nat Rev Drug Discov (2008) 2.05
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther (2009) 1.67
Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia. Neuropsychopharmacology (2013) 1.33
Prenatal stress: role in psychotic and depressive diseases. Psychopharmacology (Berl) (2010) 1.29
Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults. J Cogn Neurosci (2007) 1.28
Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. PLoS One (2012) 1.27
Prepulse inhibition and genetic mouse models of schizophrenia. Behav Brain Res (2009) 1.20
Are we studying and treating schizophrenia correctly? Schizophr Res (2011) 1.19
Advances in endophenotyping schizophrenia. World Psychiatry (2008) 1.18
Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res (2007) 1.11
Profile of auditory information-processing deficits in schizophrenia. Psychiatry Res (2008) 1.11
Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model. PLoS One (2009) 1.10
Transcription factor SP4 is a susceptibility gene for bipolar disorder. PLoS One (2009) 1.10
Strain differences in the gating-disruptive effects of apomorphine: relationship to gene expression in nucleus accumbens signaling pathways. Biol Psychiatry (2008) 1.04
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity. J Psychopharmacol (2011) 1.02
Synaptosomal-associated protein 25 mutation induces immaturity of the dentate granule cells of adult mice. Mol Brain (2013) 1.01
Neural substrates of normal and impaired preattentive sensory discrimination in large cohorts of nonpsychiatric subjects and schizophrenia patients as indexed by MMN and P3a change detection responses. Neuroimage (2012) 1.00
Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia. Am J Psychiatry (2014) 0.99
Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. Schizophr Res (2007) 0.98
Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders. Curr Top Behav Neurosci (2012) 0.97
Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families. Psychiatry Res (2010) 0.96
Cortical grey matter volume and sensorimotor gating in schizophrenia. Cortex (2008) 0.95
Frontal-striatal-thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gating. Neuroimage (2008) 0.95
Brief subjective durations contract with repetition. J Vis (2008) 0.94
Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS. Schizophr Res (2014) 0.94
Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers. Neuropsychopharmacology (2010) 0.94
Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44. Pharmacol Biochem Behav (2009) 0.93
Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor. Exp Neurol (2009) 0.92
Sensorimotor gating in neurotensin-1 receptor null mice. Neuropharmacology (2009) 0.91
Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patients. Neuropsychopharmacology (2007) 0.91
Uncontrollable voices and their relationship to gating deficits in schizophrenia. Schizophr Res (2008) 0.88
Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia. Front Synaptic Neurosci (2014) 0.87
Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia. Ann N Y Acad Sci (2015) 0.87
Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Neuropsychopharmacology (2011) 0.87
Reduced prepulse inhibition in adolescents at risk for psychosis: a 2-year follow-up study. J Psychiatry Neurosci (2011) 0.87
Impaired prepulse inhibition and prepulse-elicited reactivity but intact reflex circuit excitability in unmedicated schizophrenia patients: a comparison with healthy subjects and medicated schizophrenia patients. Schizophr Bull (2008) 0.87
BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulation. Front Cell Neurosci (2013) 0.86
Startle reactivity and prepulse inhibition in prodromal and early psychosis: effects of age, antipsychotics, tobacco and cannabis in a vulnerable population. Psychiatry Res (2011) 0.86
Reelin haploinsufficiency reduces the density of PV+ neurons in circumscribed regions of the striatum and selectively alters striatal-based behaviors. Psychopharmacology (Berl) (2009) 0.85
Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice. Psychopharmacology (Berl) (2007) 0.84
The association of schizophrenia risk D-amino acid oxidase polymorphisms with sensorimotor gating, working memory and personality in healthy males. Neuropsychopharmacology (2011) 0.84
Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice. Br J Pharmacol (2009) 0.84
Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex. Psychopharmacology (Berl) (2011) 0.84
Clonidine normalizes sensorimotor gating deficits in patients with schizophrenia on stable medication. Schizophr Bull (2012) 0.84
Toxoplasma gondii exposure affects neural processing speed as measured by acoustic startle latency in schizophrenia and controls. Schizophr Res (2013) 0.84
An Overview of the Association between Schizotypy and Dopamine. Front Psychiatry (2014) 0.84
Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis. Neuropsychopharmacology (2015) 0.84
Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders. Biochem Pharmacol (2015) 0.84
Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome. Neurosci Biobehav Rev (2012) 0.84
Effects of periadolescent fluoxetine and paroxetine on elevated plus-maze, acoustic startle, and swimming immobility in rats while on and off-drug. Behav Brain Funct (2011) 0.83
Prepulse inhibition in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc (2013) 0.83
Structural brain correlates of sensorimotor gating in antipsychotic-naive men with first-episode schizophrenia. J Psychiatry Neurosci (2013) 0.83
Sensorimotor gating and clinical outcome following cognitive behaviour therapy for psychosis. Schizophr Res (2011) 0.82
Cortico-subcortical neuromodulation involved in the amelioration of prepulse inhibition deficits in dopamine transporter knockout mice. Neuropsychopharmacology (2012) 0.81
Evidence for a role of progesterone in menstrual cycle-related variability in prepulse inhibition in healthy young women. Neuropsychopharmacology (2009) 0.81
Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats. Psychopharmacology (Berl) (2014) 0.80
The mGluR2/3 agonist LY379268 blocks the effects of GLT-1 upregulation on prepulse inhibition of the startle reflex in adult rats. Neuropsychopharmacology (2010) 0.80
Acute or subchronic clozapine treatment does not ameliorate prepulse inhibition (PPI) deficits in CPB-K mice with low levels of hippocampal NMDA receptor density. Psychopharmacology (Berl) (2007) 0.80
Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption. Front Pharmacol (2012) 0.80
Towards medication-enhancement of cognitive interventions in schizophrenia. Handb Exp Pharmacol (2012) 0.80
Acoustic prepulse inhibition: one ear is better than two, but why and when? Psychophysiology (2014) 0.80
Lack of relationship between acoustic startle and cognitive variables in schizophrenia and control subjects. Psychiatry Res (2011) 0.79
Molecular-genetic mapping of zebrafish mutants with variable phenotypic penetrance. PLoS One (2011) 0.79
Prenatal immune challenge in rats: effects of polyinosinic-polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamine. Neurotoxicol Teratol (2014) 0.79
Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats. Psychopharmacology (Berl) (2010) 0.79
Sensory and sensorimotor gating-disruptive effects of apomorphine in Sprague Dawley and Long Evans rats. Behav Brain Res (2010) 0.79
Projections from ventral hippocampus to medial prefrontal cortex but not nucleus accumbens remain functional after fornix lesions in rats. Neuroscience (2010) 0.78
Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History. Am J Psychiatry (2015) 0.78
Reduction in phencyclidine induced sensorimotor gating deficits in the rat following increased system xc⁻ activity in the medial prefrontal cortex. Psychopharmacology (Berl) (2012) 0.78
Contrasting effect of prepulse signals on performance of Toxoplasma-infected and Toxoplasma-free subjects in an acoustic reaction times test. PLoS One (2014) 0.78
Prepulse inhibition of startle response: recent advances in human studies of psychiatric disease. Clin Psychopharmacol Neurosci (2011) 0.77
Sensory gating disturbances in the spectrum: similarities and differences in schizotypal personality disorder and schizophrenia. Schizophr Res (2014) 0.77
Neural correlates of sensorimotor gating: a metabolic positron emission tomography study in awake rats. Front Behav Neurosci (2014) 0.77
In Vivo Ca(2+) Imaging Reveals that Decreased Dendritic Excitability Drives Startle Habituation. Cell Rep (2015) 0.77
Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats. Psychopharmacology (Berl) (2007) 0.77
Hypnotizability, hypnosis and prepulse inhibition of the startle reflex in healthy women: an ERP analysis. PLoS One (2013) 0.76
Reductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist. Psychopharmacology (Berl) (2015) 0.76
Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia. Cell Rep (2016) 0.76
Sensorimotor gating, cannabis use and the risk of psychosis. Schizophr Res (2015) 0.76
MitoPark mice, an animal model of Parkinson's disease, show enhanced prepulse inhibition of acoustic startle and no loss of gating in response to the adenosine A(2A) antagonist SCH 412348. Psychopharmacology (Berl) (2013) 0.76
Dexamphetamine effects on prepulse inhibition (PPI) and startle in healthy volunteers. Psychopharmacology (Berl) (2013) 0.76
Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine. Neuropharmacology (2012) 0.76
A Methionine-Induced Animal Model of Schizophrenia: Face and Predictive Validity. Int J Neuropsychopharmacol (2015) 0.75
Deficits of perceived spatial separation induced prepulse inhibition in patients with schizophrenia: relationships to symptoms and neurocognition. BMC Psychiatry (2017) 0.75
Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourette's Syndrome in Preclinical Studies. Front Neurosci (2016) 0.75
Epistatic and Independent Effects on Schizophrenia-Related Phenotypes Following Co-disruption of the Risk Factors Neuregulin-1 × DISC1. Schizophr Bull (2016) 0.75
Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy. Front Pharmacol (2016) 0.75
Emotional Contagion is not Altered in Mice Prenatally Exposed to Poly (I:C) on Gestational Day 9. Front Behav Neurosci (2016) 0.75
Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry. Neuropsychopharmacology (2014) 0.75
Sensorimotor gating in healthy adults tested over a 15 year period. Biol Psychol (2016) 0.75
Electroconvulsive shock attenuated microgliosis and astrogliosis in the hippocampus and ameliorated schizophrenia-like behavior of Gunn rat. J Neuroinflammation (2016) 0.75
Is Schizophrenia a Disorder of Consciousness? Experimental and Phenomenological Support for Anomalous Unconscious Processing. Front Psychol (2017) 0.75
Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia. Neuropsychopharmacology (2017) 0.75
Rivastigmine improves isolation rearing-induced prepulse inhibition deficits via muscarinic acetylcholine receptors in mice. Psychopharmacology (Berl) (2015) 0.75
Predictors of smoking reduction outcomes in a sample of 287 patients with schizophrenia spectrum disorders. Eur Arch Psychiatry Clin Neurosci (2015) 0.75
At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry (2011) 3.66
North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull (2007) 3.28
Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell (2013) 3.26
Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull (2006) 2.92
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull (2009) 2.90
Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) (2008) 2.64
Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry (2010) 2.54
Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull (2005) 2.50
Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients. Biol Psychiatry (2006) 2.25
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull (2006) 1.88
Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study. Biol Psychiatry (2013) 1.87
Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Arch Gen Psychiatry (2005) 1.87
Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophr Res (2006) 1.80
North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res (2012) 1.79
Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology (2002) 1.76
Chaos and schizophrenia: does the method fit the madness? Biol Psychiatry (2003) 1.57
Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacology (Berl) (2004) 1.47
MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PLoS One (2011) 1.47
Risk factors for psychosis: impaired social and role functioning. Schizophr Bull (2011) 1.43
The value of referring to recently introduced antipsychotics as "second generation". Am J Psychiatry (2003) 1.43
Stability of mismatch negativity deficits and their relationship to functional impairments in chronic schizophrenia. Am J Psychiatry (2005) 1.38
Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol. Am J Psychiatry (2007) 1.32
Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res (2012) 1.32
Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Res (2007) 1.32
Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2013) 1.30
Frequency-specific alternations in the amplitude of low-frequency fluctuations in schizophrenia. Hum Brain Mapp (2012) 1.29
Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res (2008) 1.29
Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia. PLoS One (2012) 1.28
Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults. J Cogn Neurosci (2007) 1.28
Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. PLoS One (2012) 1.27
Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res (2006) 1.25
How does studying schizotypal personality disorder inform us about the prodrome of schizophrenia? Curr Psychiatry Rep (2005) 1.24
Social functioning in young people at risk for schizophrenia. Psychiatry Res (2007) 1.23
Course of neurocognitive deficits in the prodrome and first episode of schizophrenia. Neuropsychology (2010) 1.22
The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample. Schizophr Res (2009) 1.21
The 5-choice continuous performance test: evidence for a translational test of vigilance for mice. PLoS One (2009) 1.20
Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry (2008) 1.19
Advances in endophenotyping schizophrenia. World Psychiatry (2008) 1.18
Cognitive, neurophysiological, and functional correlates of proverb interpretation abnormalities in schizophrenia. J Int Neuropsychol Soc (2007) 1.15
The relationship of age to prepulse inhibition and habituation of the acoustic startle response. Biol Psychol (2003) 1.15
An event-related brain potential study of direct and indirect semantic priming in schizophrenia. Am J Psychiatry (2007) 1.14
P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment. Biol Psychiatry (2005) 1.13
Neural correlates of refixation saccades and antisaccades in normal and schizophrenia subjects. Biol Psychiatry (2002) 1.13
The relationship between preattentive sensory processing deficits and age in schizophrenia patients. Clin Neurophysiol (2009) 1.12
Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res (2007) 1.11
Event-related gamma activity in schizophrenia patients during a visual backward-masking task. Am J Psychiatry (2005) 1.11
Visual masking as a probe for abnormal gamma range activity in schizophrenia. Biol Psychiatry (2003) 1.10
Sensitization and habituation of the acoustic startle reflex in patients with schizophrenia. Psychiatry Res (2004) 1.10
Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients. Biol Psychiatry (2006) 1.09
The use of neurophysiological endophenotypes to understand the genetic basis of schizophrenia. Dialogues Clin Neurosci (2005) 1.07
Substance use in clinical high risk for psychosis: a review of the literature. Early Interv Psychiatry (2013) 1.06
Reduced multisensory integration in patients with schizophrenia on a target detection task. Neuropsychologia (2010) 1.05
Hierarchical organization of gamma and theta oscillatory dynamics in schizophrenia. Biol Psychiatry (2012) 1.02
North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms. J Nerv Ment Dis (2015) 1.02
Frequency dependent alterations in regional homogeneity of baseline brain activity in schizophrenia. PLoS One (2013) 1.01
RASD2, MYH9, and CACNG2 genes at chromosome 22q12 associated with the subgroup of schizophrenia with non-deficit in sustained attention and executive function. Biol Psychiatry (2008) 1.00
γ oscillations in schizophrenia: mechanisms and clinical significance. Brain Res (2011) 0.99
Premorbid functional development and conversion to psychosis in clinical high-risk youths. Dev Psychopathol (2013) 0.99
Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr Res (2010) 0.99
Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. Schizophr Res (2007) 0.98
Parietal dysfunction is associated with increased outcome-related decision-making in schizophrenia patients. Biol Psychiatry (2002) 0.98
Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: a preliminary study. Schizophr Res (2011) 0.97
Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res (2011) 0.97